查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1738288

重組細胞培養補充劑市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、形式、應用、最終用戶、地區和競爭情況細分，2020 年至 2030 年

Recombinant Cell Culture Supplements Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Form, By Application, By End User, By Region, & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球重組細胞培養補充劑市場價值為 8.3065 億美元，預計到 2030 年將達到 15.3618 億美元，複合年成長率為 10.75%。該市場包括必需的重組蛋白，例如白蛋白、轉鐵蛋白、胰島素和細胞因子，它們在增強研究和生物製造平台上的細胞增殖、活力和生產力方面發揮著至關重要的作用。隨著生物製藥應用的不斷擴展以及無血清和非動物源性培養基的採用率不斷提高，對重組補充劑的需求激增。關鍵促進因素包括對一致且可擴展的生物製劑生產日益成長的需求、生物加工技術的創新以及治療製造中嚴格的品質標準。隨著監管審查的加強和對更安全、更合乎道德的成分的追求不斷增加，提供客製化和高性能解決方案的公司將獲得強大的競爭優勢，尤其是在高成長地區和新興生物技術公司中。

市場概覽
預測期 2026-2030
2024年市場規模 8.3065億美元
2030年市場規模 15.3618億美元
2025-2030 年複合年成長率 10.75%
成長最快的領域 重組白蛋白
最大的市場 北美洲

關鍵市場促進因素

慢性病盛行率上升

主要市場挑戰

製造成本高，生產流程複雜

主要市場趨勢

將植物藥納入主流藥物研發

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：重組細胞培養補充品市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 副產物（重組白蛋白、重組胰島素、重組轉鐵蛋白、重組細胞激素、其他）
    • 依型態（液體、粉末）
    • 按應用（生物製藥生產、再生醫學、其他）
    • 按最終用戶（製藥和生物技術公司、細胞培養基製造商、CMO 和 CRO、CDMO、學術研究機構）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美重組細胞培養補充品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲重組細胞培養補充劑市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太重組細胞培養補充品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲重組細胞培養補充品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲重組細胞培養補充劑市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球重組細胞培養補充劑市場：SWOT 分析

第 14 章：競爭格局

  • Thermo Fisher Scientific Inc
  • STEMCELL Technologies Canada Inc.
  • Merck KGaA
  • Sartorius AG
  • Lonza Group Ltd
  • miltenyi biotec
  • Capricorn Scientific
  • InVitria
  • Bio-Techne
  • Sino Biological, Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 13013

The Global Recombinant Cell Culture Supplements Market was valued at USD 830.65 Million in 2024 and is projected to reach USD 1536.18 Million by 2030, growing at a CAGR of 10.75%. This market comprises essential recombinant proteins such as albumin, transferrin, insulin, and cytokines that play a crucial role in enhancing cell proliferation, viability, and productivity across research and biomanufacturing platforms. With the continuous expansion of biopharmaceutical applications and the rising adoption of serum-free and animal-origin-free media, demand for recombinant supplements has surged. Key drivers include the growing need for consistent and scalable biologic production, innovations in bioprocessing technologies, and stringent quality standards in therapeutic manufacturing. As regulatory scrutiny intensifies and the push for safer, more ethical ingredients increases, companies offering customized and high-performance solutions are poised for strong competitive advantages, especially in high-growth regions and among emerging biotech firms.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 830.65 Million
Market Size 2030USD 1536.18 Million
CAGR 2025-203010.75%
Fastest Growing SegmentRecombinant Albumin
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Chronic Diseases

The increasing global burden of chronic diseases is a pivotal factor fueling the demand for recombinant cell culture supplements. According to the World Health Organization (2021), non-communicable diseases account for 75% of non-pandemic-related deaths worldwide. Chronic illnesses such as diabetes, cancer, cardiovascular disorders, and autoimmune conditions are escalating due to factors like population aging, lifestyle changes, and environmental stressors. These conditions often necessitate advanced biologic therapies, which rely heavily on recombinant supplements for their development and manufacturing. Recombinant proteins provide essential support for cell-based production systems used to generate monoclonal antibodies, hormones, and cytokines. As the demand for scalable and personalized therapeutic solutions rises, the need for high-quality, consistent, and safe culture supplements becomes increasingly integral to the drug development pipeline.

Key Market Challenges

High Manufacturing Costs and Complex Production Processes

The production of recombinant cell culture supplements involves intricate biotechnological methods, including microbial fermentation and mammalian cell expression systems, which require significant capital investment and technical expertise. These complex processes demand high-grade infrastructure such as bioreactors, purification systems, and quality assurance protocols to meet regulatory standards and ensure product integrity. Consequently, the high cost of production translates into premium pricing, which can restrict adoption in budget-constrained settings, especially in academic institutions and emerging markets. Additionally, issues related to batch consistency, process scalability, and regional regulatory compliance further complicate market penetration and expansion, particularly for niche or tailored formulations.

Key Market Trends

Integration of Phytopharmaceuticals into Mainstream Drug Development

A notable trend influencing the broader life sciences sector is the incorporation of phytopharmaceuticals into conventional drug development pipelines. While traditionally associated with herbal or nutraceutical applications, plant-based active pharmaceutical ingredients (APIs) are now gaining traction for their therapeutic efficacy and favorable safety profiles. Pharmaceutical firms are increasingly collaborating with research institutes and biotech startups to explore plant-derived compounds for diseases like diabetes, cancer, cardiovascular issues, and neurological disorders. Technological advances in extraction and formulation have made it feasible to commercialize these compounds with robust IP protections and enhanced bioavailability. This evolving trend highlights a broader shift in pharma R&D strategies, complementing synthetic and recombinant therapies with nature-based solutions.

Key Market Players

  • Thermo Fisher Scientific Inc
  • STEMCELL Technologies Canada Inc.
  • Merck KGaA
  • Sartorius AG
  • Lonza Group Ltd
  • miltenyi biotec
  • Capricorn Scientific
  • InVitria
  • Bio-Techne
  • Sino Biological, Inc.

Report Scope

In this report, the Global Recombinant Cell Culture Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Recombinant Cell Culture Supplements Market, By Product:

  • Recombinant Albumin
  • Recombinant Insulin
  • Recombinant Transferrin
  • Recombinant Cytokines
  • Others

Recombinant Cell Culture Supplements Market, By Form:

  • Liquid
  • Powder

Recombinant Cell Culture Supplements Market, By Application:

  • Biopharmaceutical Production
  • Regenerative Medicine
  • Other

Recombinant Cell Culture Supplements Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Cell Culture Media Manufacturers
  • CMOs & CROs
  • CDMOs
  • Academic Research Institutes

Recombinant Cell Culture Supplements Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Recombinant Cell Culture Supplements Market.

Available Customizations

Global Recombinant Cell Culture Supplements market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Recombinant Cell Culture Supplements Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Recombinant Albumin, Recombinant Insulin, Recombinant Transferrin, Recombinant Cytokines, Others)
    • 5.2.2. By Form (Liquid, Powder)
    • 5.2.3. By Application (Biopharmaceutical Production, Regenerative Medicine, Other)
    • 5.2.4. By End User (Pharmaceutical & Biotechnology Companies, Cell Culture Media Manufacturers, CMOs & CROs, CDMOs, Academic Research Institutes)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Recombinant Cell Culture Supplements Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Form
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Recombinant Cell Culture Supplements Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Form
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Recombinant Cell Culture Supplements Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Form
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Recombinant Cell Culture Supplements Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Form
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Recombinant Cell Culture Supplements Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Form
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Recombinant Cell Culture Supplements Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Form
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. United Kingdom Recombinant Cell Culture Supplements Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Form
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Italy Recombinant Cell Culture Supplements Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Form
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. France Recombinant Cell Culture Supplements Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Form
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Recombinant Cell Culture Supplements Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Form
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia-Pacific Recombinant Cell Culture Supplements Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Form
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Recombinant Cell Culture Supplements Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Form
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Recombinant Cell Culture Supplements Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Form
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Recombinant Cell Culture Supplements Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Form
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Recombinant Cell Culture Supplements Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Form
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Recombinant Cell Culture Supplements Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Form
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. South America Recombinant Cell Culture Supplements Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Form
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Recombinant Cell Culture Supplements Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Form
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Recombinant Cell Culture Supplements Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Form
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Recombinant Cell Culture Supplements Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Form
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Middle East and Africa Recombinant Cell Culture Supplements Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Form
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Recombinant Cell Culture Supplements Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Form
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Recombinant Cell Culture Supplements Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Form
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Recombinant Cell Culture Supplements Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Form
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Recombinant Cell Culture Supplements Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Thermo Fisher Scientific Inc
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. STEMCELL Technologies Canada Inc.
  • 14.3. Merck KGaA
  • 14.4. Sartorius AG
  • 14.5. Lonza Group Ltd
  • 14.6. miltenyi biotec
  • 14.7. Capricorn Scientific
  • 14.8. InVitria
  • 14.9. Bio-Techne
  • 14.10.Sino Biological, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer